Education
About Us
Working with TipRanks
Follow Us
Clover Biopharmaceuticals Ltd. (HK:2197)
:2197
RESEARCH TOOLSreports
Total Valuation
Clover Biopharmaceuticals Ltd. has a market cap or net worth of HK$1.01B. The enterprise value is -HK$217.72M.
Market CapHK$1.01B
Enterprise Value-HK$217.72M
Share Statistics
Clover Biopharmaceuticals Ltd. has 1,297,119,400 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,297,119,400
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Clover Biopharmaceuticals Ltd.’s return on equity (ROE) is 0.55 and return on invested capital (ROIC) is 94.29%.
Return on Equity (ROE)0.55
Return on Assets (ROA)-1.11
Return on Invested Capital (ROIC)94.29%
Return on Capital Employed (ROCE)0.87
Revenue Per Employee128.06K
Profits Per Employee-3.01M
Employee Count300
Asset Turnover0.05
Inventory Turnover64.49
Valuation Ratios
The current PE Ratio of Clover Biopharmaceuticals Ltd. is ―. Clover Biopharmaceuticals Ltd.’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to Fair Value-0.17
Price to FCF0.00
Price to Operating Cash Flow-2.76
PEG Ratio―
Income Statement
In the last 12 months, Clover Biopharmaceuticals Ltd. had revenue of 38.42M and earned -903.43M in profits. Earnings per share was -0.72.
Revenue38.42M
Gross Profit-672.94M
Operating Income-951.21M
Pretax Income-903.43M
Net Income-903.43M
EBITDA-916.54M
Earnings Per Share (EPS)-0.72
Cash Flow
In the last 12 months, operating cash flow was -157.93M and capital expenditures -1.23M, giving a free cash flow of -159.15M billion.
Operating Cash Flow-157.93M
Free Cash Flow-159.15M
Free Cash Flow per Share-0.12
Dividends & Yields
Clover Biopharmaceuticals Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.25
52-Week Price Change196.15%
50-Day Moving Average0.43
200-Day Moving Average0.30
Relative Strength Index (RSI)77.90
Average Volume (3m)11.67M
Important Dates
Clover Biopharmaceuticals Ltd. upcoming earnings date is Aug 26, 2025, Before Open (Not Confirmed).
Last Earnings DateMar 31, 2025
Next Earnings DateAug 26, 2025
Ex-Dividend Date―
Financial Position
Clover Biopharmaceuticals Ltd. as a current ratio of 0.35, with Debt / Equity ratio of -5.48%
Current Ratio0.35
Quick Ratio0.34
Debt to Market Cap0.26
Net Debt to EBITDA0.34
Interest Coverage Ratio-165.25
Taxes
In the past 12 months, Clover Biopharmaceuticals Ltd. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Clover Biopharmaceuticals Ltd. EV to EBITDA ratio is 0.03, with an EV/FCF ratio of 0.10.
EV to Sales-0.72
EV to EBITDA0.03
EV to Free Cash Flow0.10
EV to Operating Cash Flow0.10
Balance Sheet
Clover Biopharmaceuticals Ltd. has HK$427.53M in cash and marketable securities with HK$89.64M in debt, giving a net cash position of -HK$337.88M billion.
Cash & Marketable SecuritiesHK$427.53M
Total DebtHK$89.64M
Net Cash-HK$337.88M
Net Cash Per Share-HK$0.26
Tangible Book Value Per Share-HK$1.33
Margins
Gross margin is -1751.59%, with operating margin of -2475.88%, and net profit margin of -2351.51%.
Gross Margin-1751.59%
Operating Margin-2475.88%
Pretax Margin-2351.51%
Net Profit Margin-2351.51%
EBITDA Margin-2385.64%
EBIT Margin-2485.33%
Analyst Forecast
The average price target for Clover Biopharmaceuticals Ltd. is HK$1.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price TargetHK$1.00
Price Target Upside29.87% Upside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast-1.73%
EPS Growth Forecast-689.53%